November 13, 2024
November 13, 2024
December 11, 2023
July 25, 2023
June 15, 2023
May 4, 2022
February 10, 2022
Learn about who we are, what we believe
and the people who lead us
Discover our unique scientific approach
for diseases with high unmet need.
The first and only FDA-approved
treatment for Demodex blepharitis
Explore the possibilities of our robust pipeline
to address significant unmet patient needs
Find additional corporate
and stock information.